Anthony Payne
Contributor since: 2007
Latest Articles
Alnylam Pharmaceuticals Soars on Roche Holding Collaboration
Palomar Medical Technologies: Set to Dominate the Aesthetic Laser Market?
eXegenics Inc.: New Company; New Technology
Idera, Coly Pharmaceuticals: Chemistry is the Name of the Game
Pozen's Trexima Begins Six Month FDA Review
Can MGI Pharma Overcome Weak Aloxi Sales?
Pharmaceutical Companies Coley, Idera, Dynavax: Leaders in the Use of TLRs
Altus Pharmaceuticals: Interesting Pipeline, Attractive Valuation
Pharmion: Mixed Signals Prompt Caution on 2007 Outlook
Regeneron: Exciting Technology, Inflated Stock Price
Does GTx Have the Muscle for Growth?
Eye on Acorda Therapeutics
The Future Looks Golden for Medarex
Eye on Halozyme Therapeutics
Eye on Palomar Medical Technologies
Is Momenta's Stock Plunge Justified?
Potential Acquisitions May Prove Positive For Vanda Pharmaceuticals
Eye on Alnylam: Silencing the Gene
AtheroGenics: The Clock Is Ticking
Pharmion's New Vidaza Approval Sends Stock Soaring
Pharmion Stock Price Sees Significant Increase: Will This Trend Continue?
Eye on Trubion Pharmaceuticals
Eye on Vanda Pharmaceuticals
Eye on Halozyme Therapeutics